Spondyloarthritis. Treat-to-target in spondyloarthritis--do we have a plan?
Level V
Where this comes from
- Record sourced from PubMed, PMID 23917954.
- Also identified by DOI 10.1038/nrrheum.2013.123.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Clinicians now have the therapies and outcome tools to implement treat-to-target strategies aimed at achieving and maintaining adequate function and control of symptoms in spondyloarthritis and psoriatic arthritis. However, validation of surrogate markers of structural progression is a prerequisite for treat-to-target strategies aimed at improving long-term outcomes such as joint damage.
Medical subject headings
- Antirheumatic Agents
- Disease Management
- Disease Progression
- Spondylarthritis